← Back to patent-cliff list
CAS 35897-34-8
(S)-2-((tert-butoxycarbonyl)amino)-5-guanidinopentanoic acid hydrochloride
Codes: CIRA-002
Application context (from source-drug indications)
出血性疾病Ciraparantag
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ciraparantag | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3,3'-(piperazine-1,4-diyl)bis(propan-1-amine)→(S)-2-((tert-butoxycarbonyl)amino)-5-guanidinopentanoic acid hydrochloride→di-tert-butyl ((2S,2'S)-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(azanediyl))bis(5-guanidino-1-oxopentane-2,1-diyl))dicarbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.